Detalhe da pesquisa
1.
Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism.
Cell
; 175(7): 1780-1795.e19, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30392958
2.
MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function.
Immunity
; 55(1): 65-81.e9, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767747
3.
Obesity induces PD-1 on macrophages to suppress anti-tumour immunity.
Nature
; 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38867043
4.
Cell-programmed nutrient partitioning in the tumour microenvironment.
Nature
; 593(7858): 282-288, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33828302
5.
Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T Cells.
J Immunol
; 211(4): 563-575, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37341499
6.
VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesis.
J Clin Invest
; 134(8)2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38618956
7.
Immunogenicity in renal cell carcinoma: shifting focus to alternative sources of tumour-specific antigens.
Nat Rev Nephrol
; 19(7): 440-450, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36973495
8.
Tissue-Specific Dependence of Th1 Cells on the Amino Acid Transporter SLC38A1 in Inflammation.
bioRxiv
; 2023 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37745344
9.
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy.
Sci Immunol
; 8(83): eadd1153, 2023 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146128
10.
Modeling clear cell renal cell carcinoma and therapeutic implications.
Oncogene
; 39(17): 3413-3426, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32123314
11.
Mutant KRAS Exosomes Alter the Metabolic State of Recipient Colonic Epithelial Cells.
Cell Mol Gastroenterol Hepatol
; 5(4): 627-629.e6, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29930982